Morrison & Foerster’s global Life Sciences Group is comprised of corporate, transactional, intellectual property, and litigation attorneys who share the value our clients place on the marriage of scientific and business success. We bring superior technical knowledge and business experience for our clients working at the pinnacle of innovation.
We represent more than 550 life sciences companies, research institutions, and venture capital funds and investment banks that finance them. With more than 180 life sciences lawyers around the world, our fully-integrated team has the depth of practice and global reach that are critical in today’s global life sciences market.
We have cultivated a practice that, like our clients’ businesses, is driven by science. Our knowledge and superior experience in pharmaceuticals, biologics, diagnostics, medical devices, vaccines, and over-the-counter products means that we understand the complex technologies at the heart of our clients’ businesses.
PRACTICE EXPERTISE: A FULLY-INTEGRATED TEAM
Among our resources is one of the largest and most recognized patent practices devoted to life sciences of any full-service law firm, with attorneys who have been involved in the development of the life sciences industry for decades. With deep understanding of how patents fit into a company’s larger business model and commercial strategy, our patent attorneys assist clients with developing and monetizing their patent portfolios, crafting an IP strategy that aligns with their business objectives and goals, and providing counsel to ensure our clients remain competitive in the industry. Our team has played a leading role in the creation and protection of many of the landmark patent portfolios in the life sciences.
It’s this combination of scientific prowess and the acumen of our business lawyers and litigators that sets our practice apart. Our corporate attorneys advise life sciences companies on issues involving corporate governance and formation, mergers and acquisitions, public offerings, public and private debt, and equity financing transactions. Since 2004, we have represented life sciences clients in more than 200 venture capital financings, valued in total at over $3 billion, and completed more than 200 M&A transactions in the life sciences sector. Since 2014, we have completed more than 25 life sciences M&A deals, with a total deal value of more than $14.4 billion.
Our technology transactions attorneys advise on the full range of transactions that arise during the life cycle of products, from billion dollar global collaborations to daily commercial and operational matters. Our transactional attorneys are leaders in structuring and negotiating arrangements in the areas of licensing and technology transfers; strategic collaborations; joint ventures; drug discovery; research and development; manufacturing and supply; distribution, marketing and co-promotion; and pre-clinical and clinical trials.
Our life sciences litigators are widely recognized for their work on IP, product liability, employment and labor, appellate, securities, antitrust, white collar criminal defense, trade secrets, and commercial litigation matters. Aggressively defending our clients’ interests, our team is among the most active litigation departments in the world, and is renowned in the courtroom for, whenever possible, keeping our clients out of the courtroom.
GLOBAL PRESENCE: INTERNATIONAL REACH
Our life sciences practice is truly global–-one of very few firms that can say that. In addition to the strength of our U.S. team, our practice includes top-tier attorneys strategically located across Europe and Asia. In Japan, our size and depth of practice are unparalleled by any other international law firm. We represent some of the largest and most active participants in the Japanese life sciences industry, counsel start-up and emerging Japanese companies in the field, and advise international clients on life sciences matters in Japan. Meanwhile, in China, with our long history and deep experience, we are perfectly poised to counsel clients entering, expanding within, and growing outside of the emerging Chinese life sciences market. In Europe, our team offers deep transactional expertise and is renowned for the depth of its life sciences industry knowledge.
Indeed, MoFo is on the cutting edge of the global interplay between science and business. With our depth of technological expertise, wealth of business insight, renowned legal skill, and global presence, our attorneys are helping clients strike the balance between innovative discovery and purposeful business planning to assure their continued success.
U.S. News – Best Lawyers® Best Law Firms 2018 National: Biotechnology Law (Tier 1) Los Angeles: Biotechnology Law (Tier 1) San Diego: Biotechnology Law (Tier 1) San Francisco: Biotechnology Law (Tier 1)
Chambers Global 2018 Global: Life Sciences Asia-Pacific Region: Life Sciences
Chambers USA 2017 National: Life Sciences California: Life Sciences
Chambers Asia Pacific 2018 Asia-Pacific Region: Life Sciences Life Sciences (International Firms): China Life Sciences (International Firms): Japan
Managing Intellectual Property Shortlist 2018 United States: Life Sciences IP Litigation
LMG Life Sciences 2017 Hatch-Waxman Patent Litigation Patent Prosecution (Highly Recommended) Patent Strategy and Management (Highly Recommended)
Here is what they say about us:
“Solid teams in the USA and Asia offer broad expertise in transactions and IP work. Noted for its capabilities in capital markets transactions and is well known for patent matters, providing specialists for litigation and prosecution. Assists key international clients in the life sciences sector.” (Chambers Global 2017)
“Clients say cases are run efficiently, effectively, with consideration of the budget and ultimately end up in an agreeable outcome.” (Chambers USA 2017)
“Particularly well known for its outstanding IP litigation, prosecution and licensing capabilities. Also adept at handling significant transactions in the sector, including strategic alliances and M&A.” (Chambers USA 2015)
“Active in the corporate transactions space and also well known for IP work in the USA and Europe. Provides strategic advice to clients in relation to acquisitions and collaborations.” (Chambers Global 2015)
“Handles significant corporate transactions for leading life sciences clients, including M&A, strategic partnerships and IPOs. Also offers outstanding expertise in IP licensing and enforcement matters in the USA, with strong support from teams in Japan and China.” (Chambers Global 2014)
Litigation Powerhouse 2016
“Handles significant corporate transactions for leading life sciences clients, including M&A, strategic partnerships and IPOs. Also offers outstanding expertise in IP licensing and enforcement matters in the USA, with strong support from teams in Japan and China.” (Chambers Global )
Recognized by U.S. News – Best Lawyers® Best Law Firms 2018 as a Tier 1 firm in biotechnology law.
©1996-2018 Morrison & Foerster LLP. All rights reserved.